For women who undergo a mastectomy, reconstruction is treated almost as a given. We speaks to seven women proudly defying the status quo.
Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall ...
In a second EU approval today, Johnson & Johnson got a green light for Akeega (niraparib and abiraterone acetate) for the ...
The FDA approved this combination tablet in the same population late last year based on the AMPLITUDE study data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results